Perylene Diimide Oligomer Nanoparticles with Ultrahigh Photothermal Conversion Efficiency for Cancer Theranostics

Qiuyu Gong, Jie Xing, Yinjuan Huang, Aiguo Wu*, Jing Yu*, Qichun Zhang*

*Corresponding author for this work

Research output: Journal Publications and ReviewsRGC 21 - Publication in refereed journalpeer-review

29 Citations (Scopus)

Abstract

Developing one agent that has reasonable stability and ultrahigh photothermal conversion efficiency (PTCE) for near-infrared (NIR) photothermal cancer treatment remains a great challenge, but is highly desirable. In this research, we developed a perylene diimide (PDI)-based oligomer (OPDI) through coupling monomeric PDI derivatives together. OPDI exhibited slightly red-shifted absorption at NIR region compared with monomeric PDI. More importantly, the self-assembled OPDI nanoparticles not only exhibited high stability and preferable biocompatibility, but also possessed an ultrahigh PTCE (up to 79.8%, higher than many other photothermal agents reported before). This OPDI photothermal agent has been demonstrated to exhibit excellent therapeutic effects. Our research provides a guide for the exploitation of photothermal agents with ultrahigh PTCE.

© 2020 American Chemical Society
Original languageEnglish
Pages (from-to)1607-1615
JournalACS Applied Bio Materials
Volume3
Issue number3
Online published14 Feb 2020
DOIs
Publication statusPublished - 16 Mar 2020
Externally publishedYes

Research Keywords

  • perylene diimides
  • phototheranostics
  • photothermal agent
  • photothermal conversion efficiency
  • self-assembly

Fingerprint

Dive into the research topics of 'Perylene Diimide Oligomer Nanoparticles with Ultrahigh Photothermal Conversion Efficiency for Cancer Theranostics'. Together they form a unique fingerprint.

Cite this